Please wait a minute...
文章检索
预防医学  2024, Vol. 36 Issue (9): 750-754    DOI: 10.19485/j.cnki.issn2096-5087.2024.09.004
  论著 本期目录 | 过刊浏览 | 高级检索 |
2011—2021年宁波市儿童青少年糖尿病发病趋势
薛喆1, 王思嘉2, 卢兰兰3, 王永2, 龚清海2, 沈鹏1
1.宁波市鄞州区疾病预防控制中心健康教育与慢性病防制科,浙江 宁波 315100;
2.宁波市疾病预防控制中心,浙江 宁波 315010;
3.宁波市鄞州区下应街道社区卫生服务中心,浙江 宁波 315100
Trend in incidence of diabetes among children and adolescents in Ningbo City from 2011 to 2021
XUE Zhe1, WANG Sijia2, LU Lanlan3, WANG Yong2, GONG Qinghai2, SHEN Peng1
1. Department of Health Education and Chronic Disease Control and Prevention, Yinzhou District Centre for Disease Control and Prevention, Ningbo, Zhejiang 315100, China;
2. Ningbo Center for Disease Control and Prevention, Ningbo, Zhejiang 315010, China;
3. Xiaying Community Health Service Center, Yinzhou District, Ningbo, Zhejiang 315100, China
全文: PDF(897 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2011—2021年浙江省宁波市儿童青少年糖尿病发病趋势,为儿童青少年糖尿病防制提供依据。方法 通过宁波市慢性病协同管理系统糖尿病监测平台收集2011—2021年宁波市0~18岁儿童青少年糖尿病发病资料,计算粗发病率并采用2010年第六次全国人口普查数据标化;采用平均年度变化百分比(AAPC)分析发病趋势。结果 2011—2021年宁波市报告儿童青少年糖尿病701例,粗发病率和标化发病率分别为6.86/10万和7.27/10万,呈上升趋势(AAPC=5.886%、7.147%,均P<0.05)。1型糖尿病粗发病率和标化发病率分别为3.36/10万和3.35/10万,未见变化趋势(AAPC=1.229%、1.449%,均P>0.05);10~<15岁组粗发病率为4.56/10万,高于其他年龄组;女性标化发病率为3.49/10万,高于男性的3.04/10万;城市标化发病率为3.60/10万,高于农村的3.15/10万(均P<0.05)。2型糖尿病粗发病率和标化发病率分别为3.43/10万和3.87/10万,呈上升趋势(AAPC=4.904%、7.579%,均P<0.05);15~18岁组粗发病率为10.53/10万,高于其他年龄组(均P<0.05),10~<15岁和15~18岁组粗发病率呈上升趋势(AAPC=15.030%、6.637%,均P<0.05);男性标化发病率为4.01/10万,高于女性的3.57/10万(P<0.05);城市标化发病率为4.57/10万,高于农村的3.34/10万(P<0.05)。结论 2011—2021年宁波市儿童青少年2型糖尿病发病率呈上升趋势,病例以15~18岁、男性和城市儿童青少年为主;1型糖尿病未见变化趋势,病例以10~<15岁、女性和城市儿童青少年为主。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
薛喆
王思嘉
卢兰兰
王永
龚清海
沈鹏
关键词 糖尿病发病率儿童青少年    
AbstractObjective To investigate the incidence trend of diabetes among children and adolescents in Ningbo City, Zhejiang Province from 2011 to 2021, so as to provide the basis for the prevention and control of diabetes among children and adolescents. Methods Data on diabetes incidence among children and adolescents aged 0 to 18 years in Ningbo City were collected through the Diabetes Monitoring Platform of the Ningbo Chronic Disease Collaborative Management System from 2011 to 2021. Crude incidence rates were calculated and standardized using data from the Sixth National Population Census in 2010. The trend of incidence rates were analyzed by average annual percent change (AAPC). Results A total of 701 cases of diabetes among children and adolescents were reported in Ningbo City from 2011 to 2021. The crude and standardized incidence rates were 6.86/105 and 7.27/105, respectively, showing upward trends (AAPC=5.886%, 7.147%, both P<0.05). The crude and standardized incidence rates of type 1 diabetes mellitus were 3.36/105 and 3.35/105, respectively, with no significant trend observed (AAPC=1.229%, 1.449%, both P>0.05). The crude incidence rate was higher in children and adolescents aged 10 to <15 years (4.56/105) than in other age groups (all P<0.05). The standardized incidence rate was higher in females than in males (3.49/105 vs. 3.04/105, P<0.05). The standardized incidence rate was higher in urban areas than in rural areas (3.60/105 vs. 3.15/105, P<0.05). The crude and standardized incidence rates of type 2 diabetes mellitus were 3.43/105 and 3.87/105, respectively, showing upward trends (AAPC=4.904%, 7.579%, both P<0.05). The crude incidence rate was higher in children and adolescents aged 15 to 18 years (10.53/105) than in other groups (all P<0.05). The crude incidence rates in children and adolescents who aged 10 to <15 years and 15 to 18 years showed upward trends (AAPC=15.030%, 6.637%, both P<0.05). The standardized incidence rate was higher in males than in females (4.01/105 vs. 3.57/105, P<0.05). The standardized incidence rate was higher in urban areas than in rural areas (4.57/105 vs. 3.34/105, P<0.05). Conclusions From 2011 to 2021, the incidence of type 2 diabetes mellitus showed an upward trend, with cases mainly concentrated in children and adolescents aged 15 to 18 years, males, and those living in urban areas. The incidence of type 1 diabetes mellitus remained stable, with cases mainly concentrated in children and adolescents aged 10 to <15 years, females, and those living in urban areas.
Key wordsdiabetes    incidence    children and adolescents
收稿日期: 2024-05-30      修回日期: 2024-08-19      出版日期: 2024-09-10
中图分类号:  R587.1  
基金资助:宁波市公益类科技项目(2022S077); 宁波市市重大科技攻关暨“揭榜挂帅”项目(2021Z054)
作者简介: 薛喆,硕士,医师,主要从事慢性病防制工作
通信作者: 沈鹏,E-mail:shen-peng@foxmail.com   
引用本文:   
薛喆, 王思嘉, 卢兰兰, 王永, 龚清海, 沈鹏. 2011—2021年宁波市儿童青少年糖尿病发病趋势[J]. 预防医学, 2024, 36(9): 750-754.
XUE Zhe, WANG Sijia, LU Lanlan, WANG Yong, GONG Qinghai, SHEN Peng. Trend in incidence of diabetes among children and adolescents in Ningbo City from 2011 to 2021. Preventive Medicine, 2024, 36(9): 750-754.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2024.09.004      或      https://www.zjyfyxzz.com/CN/Y2024/V36/I9/750
[1] SUN H,SAEEDI P,KARURANGA S,et al.IDF Diabetes Atlas:global,regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract,2022,183:1-23.
[2] WU H J,PATTERSON C C,ZHANG X G,et al.Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021[J].Diabetes Res Clin Pract,2022,185:1-8.
[3] YOSHIDA Y,SIMOES E J.Sugar-sweetened beverage,obesity,and type 2 diabetes inchildren and adolescents:policies,taxation,and programs[J].Curr Diab Rep,2018,18(6):31-47.
[4] WU H B,ZHONG J M,HU R Y,et al.Rapidly rising incidence of type 1 diabetes in children and adolescents aged 0-19 years in Zhejiang,China,2007 to 2013[J].Diabet Med,2016,33(10):1339-1346.
[5] WU H B,ZHONG J M,YU M,et al.Incidence and time trends of type 2 diabetes mellitus in youth aged 5-19 years:a population-based registry in Zhejiang,China,2007 to 2013[J].BMC Pediatr,2017,17(1):85-92.
[6] BESSER R E J,BELL K J,COUPER J J,et al.ISPAD Clinical Practice Consensus Guidelines 2022:stages of type 1 diabetes in children and adolescents[J].Pediatr Diabetes,2022,23(8):1175-1187.
[7] SHAH A S,ZEITLER P S,WONG J,et al.ISPAD Clinical Practice Consensus Guidelines 2022:type 2 diabetes in children and adolescents[J].Pediatr Diabetes,2022,23(7):872-902.
[8] WANG J L,WU W,DONG G P,et al.Pediatric diabetes in China:challenges and actions[J].Pediatr Diabetes,2022,23(5):545-550.
[9] 毛彬,罗楚红,曾媛,等.2013—2023年儿童糖尿病研究热点与趋势的文献计量学分析[J].中国儿童保健杂志,2024,32(5):552-558.
[10] WANG L M,PENG W,ZHAO Z P,et al.Prevalence and treatment of diabetes in China,2013-2018[J].JAMA,2021,326(24):2498-2506.
[11] WENG J P,ZHOU Z G,GUO L X,et al.Incidence of type 1 diabetes in China,2010-13:population based study[J].BMJ,2018,360:1-9.
[12] KHADILKAR A,OZA C,MONDKAR S A.Insulin resistance in adolescents and youth with type 1 diabetes:a review of problems and solutions[J].Clin Med Insights Endocrinol Diabetes,2023,16:1-10.
[13] ZABEEN B,MANIAM J,BALSA A M M,et al.Incidence of diabetes in children and adolescents in Dhaka,Bangladesh[J].J Pediatr Endocr Met,2021,34(4):509-515.
[14] 汪会琴,胡如英,武海滨,等.2型糖尿病报告发病率研究进展[J].预防医学,2016,28(1):37-39,57.
[15] 史碧君,张琰,高华,等.宁波市中小学生肥胖现状及影响因素的研究[J].中国卫生检验杂志,2020,30(16):2018-2020.
[16] SINGHAL S,KUMAR S.Current perspectives on management of type 2 diabetes in youth[J].Children(Basel),2021,8(1):37-52.
[17] 高雷,孟佳,李娟娟,等.浙江省7~22岁学生超重肥胖现况调查[J].预防医学,2021,33(12):1215-1219.
[18] 孙霞,朱艳,郑鹏,等.超重肥胖和2型糖尿病对瘦素、内脂素的影响研究[J].预防医学,2022,34(6):581-585.
[19] KILIC G,ALVAREZ-MERCADO A I,ZARROUKI B,et al.The islet estrogen receptor-α is induced by hyperglycemia and protects against oxidative stress-induced insulin-deficient diabetes[J].PLoS One,2014,9(2):1-9.
[1] 韩亚蓉, 韩颖颖, 蔡波, 林玲. 2013—2022年南通市甲状腺癌发病和死亡趋势分析[J]. 预防医学, 2026, 38(1): 20-25.
[2] 周凡, 王小红, 陈梦倩, 张小兰, 徐则林. 2016—2027年金华市结直肠癌发病和死亡趋势分析及预测[J]. 预防医学, 2026, 38(1): 26-30.
[3] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[4] 卢文海, 孔校杰, 宋丽霞, 卢春如, 于碧鲲, 谢延. SARIMA、Prophet与BSTS模型预测手足口病发病率的效果比较[J]. 预防医学, 2026, 38(1): 79-84.
[5] 陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[6] 李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
[7] 李君, 朱婷婷, 胡文雪. 2005—2023年温州市丙型病毒性肝炎流行特征分析[J]. 预防医学, 2025, 37(9): 932-936.
[8] 胡晓强, 刘艳, 周思凡, 张子喆, 王雨达, 沈建勇. 2014—2023年湖州市流行性感冒流行特征分析[J]. 预防医学, 2025, 37(9): 959-962.
[9] 张凯慧, 李婉玲, 王彦兴, 安愿. 老年2型糖尿病患者心理灵活性、运动自我效能在衰弱与社会疏离间的中介效应分析[J]. 预防医学, 2025, 37(8): 783-788.
[10] 李克, 庞志峰, 吴晓虹, 王诚, 何瑶, 唐慧玲. 2007—2024年金华市钩端螺旋体病流行特征分析[J]. 预防医学, 2025, 37(8): 818-821.
[11] 刘明坤, 张丰香, 韩彩静, 王霞, 陈世坤, 金梅, 孙金月. 2型糖尿病患者周围神经病变风险预测模型研究[J]. 预防医学, 2025, 37(7): 692-696.
[12] 冷雪, 傅淑琴, 舒纪为, 谭启龙, 李科峰. 舟山市带状疱疹首诊病例特征分析[J]. 预防医学, 2025, 37(7): 701-704.
[13] 俞丹丹, 杨加丽, 张雅萍, 许慧琳, 何丹丹, 李俊. 2型糖尿病共病患者空腹血糖波动轨迹的影响因素研究[J]. 预防医学, 2025, 37(6): 562-567,572.
[14] 李美琳, 周梦姣, 吴佳芸, 喻喆, 孔利萍. 老年男性2型糖尿病患者合并肌少症的影响因素分析[J]. 预防医学, 2025, 37(6): 588-592.
[15] 丁哲渊, 杨研, 傅天颖, 鲁琴宝, 王心怡, 吴昊澄, 刘魁, 林君芬, 吴晨. 2024年浙江省法定传染病疫情分析[J]. 预防医学, 2025, 37(5): 433-438,442.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed